Cited by 1,709Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacySynthesis of β-Lactam Compounds

The DOI matches its Crossref record; 462 of the 464 references it cites were found in a registry or an index.

Three Decades of β-Lactamase Inhibitors

Open access

Drawz, Sarah M., Bonomo, Robert A.·2010·Clinical Microbiology Reviews

Open this paper in CoChat — free account

Abstract

Since the introduction of penicillin, beta-lactam antibiotics have been the antimicrobial agents of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened by bacterial beta-lactamases. beta-Lactamases are now responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. In order to overcome beta-lactamase-mediated resistance, beta-lactamase inhibitors (clavulanate, sulbactam, and tazobactam) were introduced into clinical practice. These inhibitors greatly enhance the efficacy of their partner beta-lactams (amoxicillin, ampicillin, piperacillin, and ticarcillin) in the treatment of serious Enterobacteriaceae and penicillin-resistant staphylococcal infections. However, selective pressure from excess antibiotic use accelerated the emergence of resistance to beta-lactam-beta-lactamase inhibitor combinations. Furthermore, the prevalence of clinically relevant beta-lactamases from other classes that are resistant to inhibition is rapidly increasing. There is an urgent need for effective inhibitors that can restore the activity of beta-lactams. Here, we review the catalytic mechanisms of each beta-lactamase class. We then discuss approaches for circumventing beta-lactamase-mediated resistance, including properties and characteristics of mechanism-based inactivators. We next highlight the mechanisms of action and salient clinical and microbiological features of beta-lactamase inhibitors. We also emphasize their therapeutic applications. We close by focusing on novel compounds and the chemical features of these agents that may contribute to a "second generation" of inhibitors. The goal for the next 3 decades will be to design inhibitors that will be effective for more than a single class of beta-lactamases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.00037-09

Cites

462 of 462 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Self-citation
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,646
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,485
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,328
AmpC β-Lactamases
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,277
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,068
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,619
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,542

Show all 464 references

Research works printed but not linked: 14

Danel, F., M. G. Page, and D. M. Livermore. 2007. Class D β-lactamases, p. 163-194. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Dubus, A., P. Ledent, J. Lamotte-Brasseur, and J. M. Frere. 1996. The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins25:473-485.
Foulds, G., W. E. Barth, J. R. Bianchine, A. R. English, D. Girard, S. L. Hayes, M. O'Brien, and P. Somani. 1980. Pharmacokinetics of CP-45.899 and pro-drug CP-47.904 in animals and humans, p. 353-356. In J. D. Nelson and C. Grassi (ed.), Current chemotherapy and infectious disease. American Society for Microbiology, Washington DC.
Galleni, M., and J. M. Frere. 2007. Kinetics of β-lactamases and pencillin-binding proteins, p. 195-213. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
F1-310. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-333a. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Livermore, D. M., M. Akova, P. J. Wu, and Y. J. Yang. 1989. Clavulanate and β-lactamase induction. J. Antimicrob. Chemother.24(Suppl. B):23-33.
A1-006. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. 2009
Meroueh, S., J. Cha, and S. Mobashery. 2007. Inhibition of class A β-lactamases, p. 101-114. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washingtion, DC.
Page, M. G. 2007. Resistance mediated by penicllin-binding proteins, p. 81-99. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for Inhibition. ASM Press, Washington, DC.
F1-311. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-0882. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Slocombe, B., A. S. Beale, R. J. Boon, K. E. Griffin, P. J. Masters, R. Sutherland, and A. R. White. 1984. Antibacterial activity in vitro and in vivo of amoxicillin in the presence of clavulanic acid, p. 29-49. InProgress and perspectives on β-lactamase inhibition: a review of Augmentin. Custom Communications: Postgraduate Medicine, New York, NY.

Sorted by citations

Items 901–1,000 of 1,001

Inhibition Mechanism of Class D β-Lactamases by Avibactam
Thakkur, V., Das, C. K., & Nair, N. N. (2022) · ACS Catalysis · doi:10.1021/acscatal.2c02693 · Cited by 12
Genetic diversity and prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in aquatic environments receiving untreated hospital effluents
Girijan, S. K., & Pillai, D. (2022) · Journal of Water and Health · doi:10.2166/wh.2022.194 · Cited by 12
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses
Alsenani, T. A., Rodríguez, M. M., Ghiglione, B., Taracila, M. A., Mojica, M. F., Rojas, L. J., Hujer, A. M., Gutkind, G., Bethel, C. R., Rather, P. N., et al. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00930-22 · Cited by 12
Self-citation
Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
Zhang, L., Cai, X., Peng, F., Tian, S., Wu, X., Li, Y., & Guo, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1182644 · Cited by 12
Antibacterial New Target Discovery: Sentinel Examples, Strategies, and Surveying Success
Sutterlin, H. A., Malinverni, J. C., Lee, S. H., Balibar, C. J., & Roemer, T. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2016_31 · Cited by 12
Phenotypic methods for screening carbapenem-resistant Enterobacteriaceae and assessment of their antimicrobial susceptibility profile
Silva, D. D. C., Rampelotto, R. F., Lorenzoni, V. V., dos Santos, S. O., Damer, J. R. D. S., Hörner, M., & Hörner, R. (2017) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0471-2016 · Cited by 12
Penicillin G's function, metabolites, allergy, and resistance.
Canzani, D., & Aldeek, F. (2017) · doi:10.35841/nutrition-human-health.1.1.28-40 · Cited by 18
Phenotypic detection of Extended Spectrum β-Lactamases (ESBL) among gram negative uropathogens reveals highly susceptibility to imipenem
Mohammed, I., & Abass, E. M. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.35.4.207 · Cited by 12
The antimicrobial susceptibility in adult invasive pneumococcal disease in the era of pneumococcus vaccination: A hospital-based observational study in Taiwan
Lee, M.-C., Kuo, K.-C., Lee, C., Hsieh, Y., Tsai, M., Huang, C., & Huang, Y. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.01.003 · Cited by 12
DeepBL: a deep learning-based approach for in silico discovery of beta-lactamases
Wang, Y., Li, F., Bharathwaj, M., Rosas, N. C., Leier, A., Akutsu, T., Webb, G. I., Marquez‐Lago, T. T., Li, J., Lithgow, T. J., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa301 · Cited by 12
Screening of natural compounds for identification of novel inhibitors against β-lactamase CTX-M-152 reported among Kluyvera georgiana isolates: An in vitro and in silico study
Hemlata, Bhat, M. A., Kumar, V., Ahmed, M. Z., Alqahtani, A. S., Alqahtani, M. S., Jan, A. T., Rahman, S., & Tiwari, A. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104688 · Cited by 12
Detection of Carbapenemase‐Producing Organisms with a Carbapenem‐Based Fluorogenic Probe
Mao, W., Xia, L., & Xie, H. (2017) · Angewandte Chemie · doi:10.1002/ange.201612495 · Cited by 12
Agricultural Wastes as an Alternative Source for the Production of Antibiotics: Recent Developments and Future Perspectives
Kashif, A., & Shahid, M. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8918-5_7 · Cited by 12
Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model
Islam, K., Sime, F. B., Wallis, S. C., Bauer, M. J., Naicker, S., Won, H. H., Zowawi, H. M., Choudhury, M. A., Shirin, T., Habib, Z. H., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00162-22 · Cited by 12
Covalent Inhibition of Serine β-Lactamases by Novel Hydroxamic Acid Derivatives
Tilvawala, R. R., & Pratt, R. F. (2013) · Biochemistry · doi:10.1021/bi4003887 · Cited by 12
Synthesis and investigation of inhibitory activities of imidazole derivatives against the metallo-β-lactamase IMP-1
Arjomandi, O. K., Kavoosi, M., & Adibi, H. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103277 · Cited by 12
Elucidating the Molecular Basis of Avibactam‐Mediated Inhibition of Class A β‐Lactamases
Das, C. K., & Nair, N. N. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202001261 · Cited by 12
The Systemic Use of Antibiotics in Periodontal Therapy
Dumitrescu, A. L. (2010) · Springer eBooks · doi:10.1007/978-3-642-13211-7_3 · Cited by 12
Antifungal agent tavaborole as a potential broad-spectrum serine and metallo-β-lactamases inhibitor
Zhang, Y., Yang, S., Deng, Z., Song, H., Xie, N., Tian, Y., Qin, S., Liu, J., Guo, Y., Wang, D., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105754 · Cited by 11
Novel antimicrobial peptide HFIAP-1 mutant as a β-lactamase inhibitor against extended-spectrum β-lactamases of Escherichia coli: a comprehensive in-silico approach
George, E. A., Naha, A., & Ramaiah, S. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04483-0 · Cited by 11
New approaches for targeting drug resistance through drug combination
Singh, S. K., Mohammed, A., Alghamdi, O. A., & Husain, S. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820576-1.00012-6 · Cited by 11
Bactericidal Action and Industrial Dye Degradation of Graphene Oxide and Polyacrylic Acid-Doped SnO 2 Quantum Dots: In Silico Molecular Docking Study
Riaz, S., Ikram, M., Naz, S., Shahzadi, A., Nabgan, W., Ul‐Hamid, A., Haider, A., Haider, J., & Al-Shanini, A. (2023) · ACS Omega · doi:10.1021/acsomega.2c07460 · Cited by 11
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase
Stewart, N. K., Tóth, M., Quan, P., Beer, M., Buynak, J. D., Smith, C. A., & Vakulenko, S. B. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00683 · Cited by 11
How Clavulanic Acid Inhibits Serine β‐Lactamases
Lang, P. A., de Munnik, M., Oluwole, A. O., Claridge, T. D. W., Robinson, C. V., Brem, J., & Schofield, C. J. (2024) · ChemBioChem · doi:10.1002/cbic.202400280 · Cited by 11
Design, synthesis and biological evaluation of non-covalent AmpC β-lactamases inhibitors
Genovese, F., Lazzari, S., Venturi, E., Costantino, L., Blázquez, J., Ibacache‐Quiroga, C., Costi, M. P., & Tondi, D. (2017) · Medicinal Chemistry Research · doi:10.1007/s00044-017-1809-x · Cited by 11
Dual-channel Microchip Electrophoresis with Amperometric Detection System for Rapid Analysis of Cefoperazone and Sulbactam
Tan, Y., Song, Q., Liu, W., Li, M., Xiao, J. R., & Chen, C. (2019) · Analytical Sciences · doi:10.2116/analsci.19p088 · Cited by 11
Influence of the α-Methoxy Group on the Reaction of Temocillin with Pseudomonas aeruginosa PBP3 and CTX-M-14 β-Lactamase
Sacco, M. D., Kroeck, K. G., Kemp, M. T., Zhang, X., Andrews, L. D., & Chen, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01473-19 · Cited by 13
Fecal Carriage and Genetic Characterization of CTX-M-1/9/1-Producing Escherichia coli From Healthy Humans in Hangzhou, China
Chen, J., Chen, S., Jiang, Y., Zhang, R., & Cai, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.616687 · Cited by 11
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
Busse, D., Simon, P., Petroff, D., Dorn, C., Schmitt, L., Bindellini, D., Kratzer, A., Dietrich, A., Zeitlinger, M. A., Huisinga, W., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091380 · Cited by 11
Pharmacokinetics of Clavulanic Acid in the Pediatric Population: A Systematic Literature Review
Keij, F. M., Tramper‐Stranders, G. A., Koch, B. C. P., Reiss, I. K. M., Muller, A. E., Kornelisse, R. F., & Allegaert, K. (2022) · Clinical Pharmacokinetics · doi:10.1007/s40262-022-01116-3 · Cited by 11
Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa
Haines, R. R., Putsathit, P., Hammer, K. A., & Tai, A. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-21101-x · Cited by 13
Preferred β-lactone synthesis can explain high rate of false-negative results in the detection of OXA-48-like carbapenemases
Študentová, V., Sudová, V., Bitar, I., Paskova, V., Moravec, J., Pompach, P., Volný, M., Novák, P., & Hrabák, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-26735-5 · Cited by 11
Molecular Signatures of the Eagle Effect Induced by the Artificial Siderophore Conjugate LP-600 in E. coli
Lai, Y.-H., Franke, R., Pinkert, L., Overwin, H., & Brönstrup, M. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00567 · Cited by 11
Rapid Detection of TEM-Type Extended-Spectrum β-Lactamase (ESBL) Mutations Using Lights-On/Lights-Off Probes with Single-Stranded DNA Amplification
Pierce, K. E., Peter, H., Bachmann, T. T., Volpe, C., Mistry, R. A., Rice, J. E., & Wangh, L. J. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.02.002 · Cited by 11
A Novel Extended-Spectrum β-Lactamase, SGM-1, from an Environmental Isolate of Sphingobium sp
Lamoureaux, T. L., Vakulenko, V., Tóth, M., Frase, H., & Vakulenko, S. B. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00808-13 · Cited by 11
Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections
Maseda, E., Aguilar, L., Giménez, M.-J., & Gilsanz, F. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.950230 · Cited by 10
Preliminary evidences of the direct and indirect antimicrobial activity of 12 plants used in traditional medicine in Africa
Catteau, L., Françoise Van Bambeke, A., & Quetin‐Leclercq, J. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-015-9437-x · Cited by 11
Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors
Sgrignani, J., Luca, F. D., Torosyan, H., Docquier, J., Duan, D., Novati, B., Prati, F., Colombo, G., & Grazioso, G. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9962-8 · Cited by 11
Reactivity of 3‐Oxo‐β‐lactams with Respect to Primary Amines—An Experimental and Computational Approach
Piens, N., Goossens, H., Hertsen, D., Deketelaere, S., Crul, L., Demeurisse, L., Moor, J. D., Broeck, E. V. D., Mollet, K., Hecke, K. V., et al. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201703852 · Cited by 11
Olive Pomace Oil can be Used as an Alternative Carbon Source for Clavulanic Acid Production by Streptomyces clavuligerus
Young, T., Li, Y., & Efthimiou, G. (2019) · Waste and Biomass Valorization · doi:10.1007/s12649-019-00719-5 · Cited by 10
Rapid Tuberculosis Diagnosis Using Reporter Enzyme Fluorescence
Sule, P., Tilvawala, R. R., Mustapha, T., Hassounah, H. A., Noormohamed, A., Kundu, S., Graviss, E. A., Walkup, G. K., Kong, Y., & Cirillo, J. D. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01462-19 · Cited by 11
Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Infektionen durch multiresistente gramnegative Stäbchen – ESBL-Bildner, Carbapenemase-bildende Enterobacteriaceae, Carbapenem-resistente Acinetobacter baumannii
Grabein, B., Ebenhoch, M., Kühnen, E., & Thalhammer, F. (2020) · PubMed Central · doi:10.3205/id000048 · Cited by 11
An integrated biophysical approach to discovering mechanisms of NDM-1 inhibition for several thiol-containing drugs
Fullington, S. A., Cheng, Z., Thomas, C. A., Miller, C., Yang, K., Ju, L., Bergström, A., Shurina, B. A., Bretz, S. L., Page, R. C., et al. (2020) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-020-01794-z · Cited by 11
New Delhi metallo-β-lactamase-1 inhibitors for combating antibiotic drug resistance: recent developments
Grewal, A. S., Thapa, K., Sharma, N., & Singh, S. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02580-x · Cited by 11
Antibiotic Adjuvants
Melander, R. J., & Melander, C. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2017_10 · Cited by 11
Materials for restoring lost Activity: Old drugs for new bugs
Pajares‐Chamorro, N., Hammer, N. D., & Chatzistavrou, X. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114302 · Cited by 11
Analysis of Extended Spectrum Beta Lactamase (ESBL) Genes of Non-Invasive ESBL Enterobacterales in Southeast Austria in 2017
Paulitsch‐Fuchs, A. H., Melchior, N., Haitzmann, T., Fingerhut, T., Feierl, G., Baumert, R., Kittinger, C., & Zarfel, G. (2022) · Antibiotics · doi:10.3390/antibiotics12010001 · Cited by 14
pH and basicity of ligands control the binding of metal-ions to B. cereus B1 β-lactamase
Motara, H., Mistry, D., Brown, D. R., Cryan, R. A., Nigen, M., & Page, M. I. (2014) · Chemical Science · doi:10.1039/c4sc00601a · Cited by 11
Structures of SHV-1 β-Lactamase with Penem and Penam Sulfone Inhibitors That Form Cyclic Intermediates Stabilized by Carbonyl Conjugation
Ke, W., Pattanaik, P., Bethel, C. R., Sheri, A., Buynak, J. D., Bonomo, R. A., & van den Akker, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049035 · Cited by 11
Self-citation
In vitro antimicrobial activity of Antibact, an herbal medicinal product against standard and clinical bacterial isolates
Felix, C. M.-R., Cynthia, I. O., Samuel, C. K. T., & Walana, W. (2015) · Journal of Medicinal Plants Research · doi:10.5897/jmpr2015.5758 · Cited by 11
Structure-based virtual screening to identify the beta-lactamase CTX-M-9 inhibitors: An in silico effort to overcome antibiotic resistance in E. coli
Davari, K., Nowroozi, J., Hosseini, F., Sepahi, A. A., & Mirzaie, S. (2017) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2017.01.009 · Cited by 11
An sRNA Screen for Reversal of Quinolone Resistance in Escherichia coli
Bhatnagar, K., Hinz, A. J., Kohlman, M., & Wong, A. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400199 · Cited by 11
Crystal structure of KPC-2 with compound 3
Akhtar, A., & Chen, Y. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6m7i/pdb · Cited by 11
Molecular Mechanisms of Antibiotic Resistance – Part II
Sharkey, L. K. R., & O’Neill, A. J. (2019) · Wiley eBooks · doi:10.1002/9781119593522.ch2 · Cited by 11
Correction: Biochemical Characterization of CTX-M-15 from Enterobacter cloacae and Designing a Novel Non-β-Lactam-β-Lactamase Inhibitor
Faheem, M., Rehman, M. T., Danishuddin, M., & Khan, A. U. (2013) · PLoS ONE · doi:10.1371/annotation/049bf1aa-d866-471f-95c1-5939d4461f8c · Cited by 11
Antimicrobials: An update on new strategies to diversify treatment for bacterial infections
Hibbert, T. M., Krpetić, Ž., Latimer, J., Leighton, H. J., McHugh, R. E., Pottenger, S., Wragg, C., & James, C. E. (2024) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2023.12.002 · Cited by 10
Rejuvenation of Meropenem by Conjugation with Tilapia Piscidin-4 Peptide Targeting NDM-1 Escherichia coli
Selvaraj, S. P., Lin, K., Lin, W., You, M., Li, T., & Chen, J. (2024) · ACS Omega · doi:10.1021/acsomega.4c03352 · Cited by 10
In silico screening of protein-binding peptides with an application to developing peptide inhibitors against antibiotic resistance
Xu, X., Kao, W.-L., Wang, A. B., Lee, H.-J., Duan, R., Holmes, H., Gallazzi, F., Ji, J., Sun, H., Heng, X., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae541 · Cited by 11
Real-world pharmacovigilance investigation of imipenem/cilastatin: signal detection using the FDA Adverse Event Reporting System (FAERS) database
Jia, P., Zhou, Y., Gao, Y., Wang, S., Yin, J., Lian, Y., & Lai, Q. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1524159 · Cited by 10
Identification of extended-spectrum-beta-lactamases(ESBLs), metallo-beta-lactamases (MBLs), Amp-C and KPC -lactamases among Klebsiella pneumoniae isolated from adults and pediatric patients in Iran
Fallah, F., Hakemi-Vala, M., Hossein, G., Ali, H., Taherpour, A., Khadijeh, B. S., Fariba, H. S., & Maliheh, H. (2013) · African Journal of Microbiology Research · doi:10.5897/ajmr12.2361 · Cited by 10
A New Covalent Inhibitor of Class C β-Lactamases Reveals Extended Active Site Specificity
Tilvawala, R. R., Cammarata, M. B., Adediran, S. A., Brodbelt, J. S., & Pratt, R. F. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01149 · Cited by 10
Semi-rational screening of the inhibitors and β-lactam antibiotics against the New Delhi metallo-β-lactamase 1 (NDM-1) producing E. coli
Wang, J., Yang, L., Yan, H., Duan, J., Luo, X., Feng, X., Lu, L., & Wang, W. (2018) · RSC Advances · doi:10.1039/c7ra12778b · Cited by 10
Complexes formed by the siderophore-based monosulfactam antibiotic BAL30072 and their interaction with the outer membrane receptor PiuA of P. aeruginosa
Scorciapino, M. A., Malloci, G., Serra, I., Milenkovic, S., Moynié, L., Naismith, J. H., Desarbre, E., Page, M. G. P., & Ceccarelli, M. (2019) · BioMetals · doi:10.1007/s10534-018-00166-0 · Cited by 10
Best Practices for Design and Characterization of Covalent Chemical Probes
Gabizon, R., Resnick, E., & London, N. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160745-00069 · Cited by 10
Molecular detection of plasmid-derived AmpC β-lactamase among clinical strains of Enterobacteriaceae in Bahrain
Joji, R. M., Al‐Mahameed, A. E., Jishi, T. A., Fatani, D. I., Saeed, N. K., Jaradat, A., Ezzat, H., & Bindayna, K. M. (2021) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_523_20 · Cited by 10
Synthesis of substituted-amidine derivatives of avibactam and synergistic antibacterial activity with meropenem
Sun, J., He, L., Gao, Y., Zhai, L., Ji, J., Liu, Y., Ji, J., Ma, X., Mu, Y., Tang, D., et al. (2021) · Mendeleev Communications · doi:10.1016/j.mencom.2021.07.020 · Cited by 10
Real‐Time Monitoring of New Delhi Metallo‐β‐Lactamase Activity in Living Bacterial Cells by 1H NMR Spectroscopy
Ma, J., McLeod, S. M., MacCormack, K., Sriram, S., Gao, N., Breeze, A. L., & Hu, J. (2014) · Angewandte Chemie · doi:10.1002/ange.201308636 · Cited by 10
Aromatic Schiff bases confer inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1)
Zhai, L., Jiang, Y., Shi, Y., Lv, M., Pu, Y.-L., Cheng, H., Zhu, J., & Yang, K. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105910 · Cited by 10
The in vitro and in vivo potential of metal-chelating agents as metallo-beta-lactamase inhibitors against carbapenem-resistant Enterobacterales
Omolabi, K. F., Reddy, N., Mdanda, S., Ntshangase, S., Singh, S. D., Kruger, H. G., Naicker, T., Govender, T., & Bajinath, S. (2022) · FEMS Microbiology Letters · doi:10.1093/femsle/fnac122 · Cited by 10
Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
Wung, C.-H., Wang, C., Lai, K., Chen, C., Chen, W., Chung, W., & Chung, W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1183491 · Cited by 10
Antibacterial Activity of Propolis Ethanol Extract against Antibiotic Resistance Bacteria Isolated from Burn Wound Infections
Farzaneh, Z., Maryam, M. S., Shams, E., & Sadat, N. N. (2014) · Zahedan Journal of Research in Medical Sciences · Cited by 10
Penam Sulfones and β-Lactamase Inhibition: SA2-13 and the Importance of the C2 Side Chain Length and Composition
Rodkey, E. A., Winkler, M., Bethel, C. R., Pagadala, S. R. R., Buynak, J. D., Bonomo, R. A., & van den Akker, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085892 · Cited by 10
Self-citation
The Role of Active Site Flexible Loops in Catalysis and of Zinc in Conformational Stability of Bacillus cereus 569/H/9 β-Lactamase
Montagner, C., Nigen, M., Jacquin, O., Willet, N., Dumoulin, M., Karsisiotis, A. I., Roberts, G. C. K., Damblon, C., Redfield, C., & Matagne, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719005 · Cited by 10
Multidrug resistance mediated by co-carriage of extended-spectrum beta-lactamases, AmpC and New Delhi metallo-beta-lactamase-1 genes among carbapenem-resistant Enterobacteriaceae at five Indian medical centres
Manoharan, A., Barla, G. S., Peter, R., Sugumar, M., & Mathai, D. (2016) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.188350 · Cited by 10
Effect of non-β-lactams on stable variants of inhibitor-resistant TEMβ-lactamase in uropathogenicEscherichia coli: implication for alternative therapy
Mukherjee, S. K., Mandal, R. S., Das, S., & Mukherjee, M. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13671 · Cited by 10
Azolylthioacetamides as potential inhibitors of New Delhi metallo-β-lactamase-1 (NDM-1)
Liu, X., Yang, X., Chen, C., & Yang, K. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0121-4 · Cited by 10
In vitro and in vivo Inhibitory Activity of NADPH Against the AmpC BER Class C β-Lactamase
Na, J., Lee, T. H., Park, S., Kim, M., Jeong, B.-G., Chung, K. M., & Cha, S. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00441 · Cited by 10
Design of dipicolinic acid derivatives as New Delhi metallo-β-lactamase-1 inhibitors using a combined computational approach
Wang, X., Gao, Y., Yu, Y., Yang, Y., Wang, G., Sun, L., & Niu, X. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1663262 · Cited by 10
Identification of Highly Selective Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors by a Covalent Fragment-Based Approach
Huang, F., Hu, H., Wang, K., Peng, C., Xu, W., Zhang, Y., Gao, J., Liu, Y., Zhou, H., Huang, R., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00372 · Cited by 11
Structural and Biochemical Characterization of the Novel CTX-M-151 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam
Ghiglione, B., Rodríguez, M. M., Brunetti, F., Papp‐Wallace, K. M., Yoshizumi, A., Ishii, Y., Bonomo, R. A., Gutkind, G., Klinke, S., & Power, P. P. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01757-20 · Cited by 10
Self-citation
Crystallography and QM/MM Simulations Identify Preferential Binding of Hydrolyzed Carbapenem and Penem Antibiotics to the L1 Metallo-β-Lactamase in the Imine Form
Twidale, R. M., Hinchliffe, P., SPENCER, J. M., & Mulholland, A. J. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00663 · Cited by 10
Transition Towards Antibiotic Hybrid Vehicles: The Next Generation Antibacterials
Kuppusamy, R., Browne, K., Suresh, D., Rosario, R. M. D., Chakraborty, S., Yang, S., Willcox, M. D. P., Black, D. S., Chen, R., & Kumar, N. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220613105424 · Cited by 10
Pharmaceutical tazobactam sodium single crystal structure determination, polymorphism and crystallization process
Wang, S., Zhao, J. B., Li, M., Qiao, R., & Li, C. (2023) · Chemical Engineering Science · doi:10.1016/j.ces.2023.118526 · Cited by 10
Detecting a Quasi-stable Imine Species on the Reaction Pathway of SHV-1 β-Lactamase and 6β-(Hydroxymethyl)penicillanic Acid Sulfone
Che, T., Rodkey, E. A., Bethel, C. R., Shanmugam, S., Ding, Z., Pusztai‐Carey, M., Nottingham, M. D., Chai, W., Buynak, J. D., Bonomo, R. A., et al. (2014) · Biochemistry · doi:10.1021/bi501197t · Cited by 10
Self-citation
New erythromycin derivatives enhance β -lactam antibiotics against methicillin-resistant Staphylococcus aureus
Li, Z., He, M., Dong, X., Lin, H., Ge, H., Shen, S., Li, J., Ye, R. D., & Chen, D. (2014) · Letters in Applied Microbiology · doi:10.1111/lam.12378 · Cited by 10
An Elusive Task: A Clinically Useful Inhibitor of Metallo-β-Lactamases
González, M. M., & Vila, A. J. (2016) · Topics in medicinal chemistry · doi:10.1007/7355_2016_6 · Cited by 10
Understanding Antibiotic Resistance
Touma, C. G. P. (2013) · Cited by 10
Βeta-Lactams as Clinically Active Medicines
Basu, S., & Banik, B. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-55621-5_9 · Cited by 10
Deciphering molecular mechanism behind conformational change of the São Paolo metallo-β-lactamase 1 by using enhanced sampling
Chen, J., Wang, J., Pang, L., Wang, W., Zhao, J., & Zhu, W. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1707121 · Cited by 11
Non-catalytic-Region Mutations Conferring Transition of Class A β-Lactamases Into ESBLs
Cao, T.-P., Yi, H., Dhanasingh, I., Ghosh, S., Choi, J. M., Lee, K. H., Ryu, S., Kim, H. S., & Lee, S. H. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.598998 · Cited by 9
Synergistic evaluation of Moringa oleifera extract and ß-lactam antibiotic to restore the susceptibility of methicillin-resistant Staphylococcus aureus
Vankwani, S., Ansari, A., Azhar, A., & Galani, S. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06889-7 · Cited by 9
Unveiling the Multifaceted Capabilities of Endophytic Aspergillus flavus Isolated from Annona squamosa Fruit Peels against Staphylococcus Isolates and HCoV 229E—In Vitro and In Silico Investigations
Fathallah, N., Elkady, W. M., Zahran, S. A., Darwish, K. M., Elhady, S. S., & Elkhawas, Y. A. (2024) · Pharmaceuticals · doi:10.3390/ph17050656 · Cited by 9
Reliability of various antimicrobial susceptibility testing methods for piperacillin/tazobactam in challenging Escherichia coli isolates
Demirocak, F., Langerak, D., & Yusuf, E. (2025) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2024.12.028 · Cited by 9
Modulation of trichloroethylene in vitro metabolism by different drugs in human
Rouhou, M. C., & Haddad, S. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.03.004 · Cited by 9
Asymmetric Synthesis of 3-Pyrrole Substituted β-Lactams Through p-Toluene Sulphonic Acid-catalyzed Reaction of Azetidine-2,3-diones with Hydroxyprolines
Banik, B. K., Yadav, R. N., Shaikh, A. L., Das, A., & Ray, D. (2022) · Current Organocatalysis · doi:10.2174/2213337209666220802105301 · Cited by 9
DeepBLI: A Transferable Multichannel Model for Detecting β-Lactamase-Inhibitor Interaction
Dong, R., Yang, H., Ai, C., Duan, G., Wang, J., & Guo, F. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01008 · Cited by 9
Gating interactions steer loop conformational changes in the active site of the L1 metallo-β-lactamase
Zhao, Z., Shen, X., Chen, S., Gu, J., Wang, H., Mojica, M. F., Samanta, M., Bhowmik, D., Vila, A. J., Bonomo, R. A., et al. (2023) · eLife · doi:10.7554/elife.83928 · Cited by 9
Self-citation
Design and development of lipid modified arginine based self-nanoemulsifying drug delivery systems for improved antibacterial activity of cefixime against S. aureus and E. coli
Rehman, K., Kanwal, T., Hamid, H. M., Ahmad, T., Perveen, S., Hasnain, M., Saifullah, S., Aziz, & Shah, M. R. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136664 · Cited by 9
Interplay between the β-lactam side chain and an active-site mobile loop of NDM-1 in penicillin hydrolysis as a potential target for mechanism-based inhibitor design
Shi, X., Dai, Y., Lan, Z., Wang, S., Cui, L., Xiao, C., Zhao, K., Li, X., Liu, W., & Zhang, Q. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130041 · Cited by 9
Screening of inhibitors for S130G inhibitor resistant mutants of TEM type beta-lactamase
Baig, M. H., Danishuddin, M., Khan, S. A., & Khan, A. U. (2012) · Bioinformation · doi:10.6026/97320630081225 · Cited by 9

Authors: Drawz, S. M., & Bonomo, R. A.
Affiliations: Departments of Pathology
United States Department of Veterans Affairs (US)
Corresponding author: Bonomo, Robert A.
ORCID: Bonomo, Robert A.
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2010-01
Volume: 23
Issue: 1
Pages: 160-201
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.00037-09
PMC: PMC2806661
OpenAlex: W1895007034
Cited by: 1,709
References: 464
Citations by year: 2026: 83 · 2025: 100 · 2024: 87 · 2023: 86 · 2022: 106 · 2021: 126 · 2020: 151 · 2019: 130 · 2018: 131 · 2017: 119 · 2016: 120 · 2015: 108 · 2014: 93 · 2013: 88 · 2012: 81
FWCI: 4.26
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (1R01A1063517-01)
National Institute of General Medical Sciences (T32GM007250, T32GM07250)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Physical Sciences › Chemistry › Organic Chemistry › Synthesis of β-Lactam Compounds
Keywords: beta-lactamase inhibitors, beta-lactamase, beta-lactam resistance, clavulanic acid, sulbactam, tazobactam, mechanism-based inactivators, carbapenemase inhibitors, extended-spectrum cephalosporin resistance, Enterobacteriaceae, penicillin-resistant staphylococci
MeSH terms: Bacteria, Bacterial Infections, Bacterial Proteins, beta-Lactamases, Enzyme Inhibitors, Humans, beta-Lactam Resistance, beta-Lactamase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Three Decades of β-Lactamase Inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks